Journal of Cancer Survivorship

, Volume 5, Issue 1, pp 113–113

Erratum to: The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer

  • Elizabeth Y. Chiao
  • Preethi V. Nimbi
  • Aanand D. Naik

Erratum to: J Cancer Surviv

DOI 10.1007/s11764-010-0141-y

The references in the original article have been published incorrectly. The correct version is provided below.


  1. 1.
    American Cancer Society. Colorectal cancer facts and figures 2008–2010. 2009.Google Scholar
  2. 2.
    Gross CP. Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc. 2006;54(12):1898–904.CrossRefPubMedGoogle Scholar
  3. 3.
    Yancik R. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer. 1998;82(11):2123–34.CrossRefPubMedGoogle Scholar
  4. 4.
    Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ et al. SEER Cancer Statistics Review, 1975–2005. 2007.Google Scholar
  5. 5.
    Williams JC. Colon carcinoma and diabetes mellitus. Cancer. 1984;54(12):3070–1.CrossRefPubMedGoogle Scholar
  6. 6.
    O’Mara BA. Diabetes mellitus and cancer risk: a multisite case-control study. J Chron Dis. 1985;38(5):435–41.CrossRefPubMedGoogle Scholar
  7. 7.
    La VC. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomark Prev. 1997;6(12):1007–10.Google Scholar
  8. 8.
    La VC. History of selected diseases and the risk of colorectal cancer. Eur J Cancer. 1991;27(5):582–6.CrossRefGoogle Scholar
  9. 9.
    Nilsen TI. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer. 2001;84(3):417–22.CrossRefPubMedGoogle Scholar
  10. 10.
    Meyerhardt JA. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003;21(3):433–40.CrossRefPubMedGoogle Scholar
  11. 11.
    Barone BB, Yeh HC, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300:2754–64.CrossRefPubMedGoogle Scholar
  12. 12.
    Siddiqui AA. Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci. 2008;53(9):286–94.Google Scholar
  13. 13.
    Keating NL. Quality of diabetes care among cancer survivors with diabetes. Med Care. 2007;45(9):869–75.CrossRefPubMedGoogle Scholar
  14. 14.
    Wattacheril J. Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther. 2008;28(9):1166–74.CrossRefPubMedGoogle Scholar
  15. 15.
    Deyo RA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–19.CrossRefPubMedGoogle Scholar
  16. 16.
    Arnold N, Sohn M, Maynard C, Hynes DM. VIReC technical Report 2: VANDI Mortality Data Merge Project. 4-9-2006.Google Scholar
  17. 17.
    El-Serag HB. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology. 2009;136(5):1601–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Polednak AP. Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev. 2006;30(5):466–72.CrossRefPubMedGoogle Scholar
  19. 19.
    Shonka NA. Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer. Med Oncol. 2006;23(4):515–19.CrossRefPubMedGoogle Scholar
  20. 20.
    Kerr EA. Making performance indicators work: experiences of US Veterans Health Administration. BMJ. 2007;335(7627):971–3.CrossRefPubMedGoogle Scholar
  21. 21.
    Jha AK. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med. 2003;348(22):2218–27.CrossRefPubMedGoogle Scholar
  22. 22.
    Nattinger AB. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992;326(17):1102–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Elizabeth Y. Chiao
    • 1
    • 2
    • 3
  • Preethi V. Nimbi
    • 1
    • 2
  • Aanand D. Naik
    • 1
    • 2
  1. 1.Houston Health Services Research and Development Center of ExcellenceMichael E. DeBakey Veterans Affairs Medical CenterHoustonUSA
  2. 2.Department of MedicineBaylor College of MedicineHoustonUSA
  3. 3.Houston Center for Quality of Care and Utilization StudiesMichael E. DeBakey VA Medical Center (152)HoustonUSA

Personalised recommendations